Pre-Seed · Biotech

Synakis Corp: Pre-Seed

Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage

Funding history

Pre-Seed · This roundCA$2.6M

Sources

  1. prnewswire.com